Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disease with poor risk prediction due to incomplete penetrance and a lack of clear genotype–phenotype correlations. Advanced imaging techniques have shown altered myocardial energetics already in preclinical gene variant carriers. To dete...
Guardado en:
Autores principales: | Maike Schuldt, Beau van Driel, Sila Algül, Rahana Y. Parbhudayal, Daniela Q. C. M. Barge-Schaapveld, Ahmet Güçlü, Mark Jansen, Michelle Michels, Annette F. Baas, Mark A. van de Wiel, Max Nieuwdorp, Evgeni Levin, Tjeerd Germans, Judith J. M. Jans, Jolanda van der Velden |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9ba77202bd64ddd8d0b7f6a3dbc9ef4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DEPENDENCE OF OUTCOMES OF HYPERTROPHIC SCARS LASER TREATMENT ON THE INITIAL REACTIVITY
por: M. V. Kobets, et al.
Publicado: (2016) -
Reactivity of an organism at hypertrophic skin scars
por: M. V. Kobets, et al.
Publicado: (2014) -
COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Milla E. Arabadjian, et al.
Publicado: (2021) -
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Martino Deidda, et al.
Publicado: (2021) -
Hypertrophic Scars and Keloids – Contemporary Concepts and Treatment Options
por: Yordanov Y. P., et al.
Publicado: (2014)